On the basis of our previous work and domain knowledge, we selected CHRNB4 for further analysis, and Western blotting was performed to validate CHRNB4 expression in NNK-treated HNSCC cells. The gene discussed is CHRNB4; the disease is head and neck squamous cell carcinoma.